ArticleCancers2021

Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials.

Bang-Bin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.